Applied DNA Sciences Partners With GenXys Health Care Systems To Enhance Precision Prescribing With TR8 Pharmacogenomic Test; Aims To Improve Patient Outcomes And Reduce Healthcare Costs Through Data-Driven Genetic Analysis
Portfolio Pulse from Benzinga Newsdesk
Applied DNA Sciences has partnered with GenXys Health Care Systems to enhance precision prescribing using the TR8 Pharmacogenomic Test. This collaboration aims to improve patient outcomes and reduce healthcare costs through data-driven genetic analysis.
June 18, 2024 | 1:11 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Applied DNA Sciences has entered into a partnership with GenXys Health Care Systems to enhance precision prescribing using the TR8 Pharmacogenomic Test. This collaboration is expected to improve patient outcomes and reduce healthcare costs through data-driven genetic analysis.
The partnership with GenXys Health Care Systems is likely to positively impact Applied DNA Sciences by enhancing its product offerings in the healthcare sector. The focus on improving patient outcomes and reducing healthcare costs through genetic analysis is a strong value proposition that could drive demand for APDN's services.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100